PyInvesting

Market research

STXS Stereotaxis, Inc

AMEX USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
142M
P/E ratio
Not available
Analyst target
4.125
Dividend yield
Not available
Beta
1.4

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Stereotaxis, Inc is currently in a long term uptrend where the price is trading 51.3% above its 200 day moving average.

From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 18.8.

Stereotaxis, Inc's total revenue sank by 1.0% to $7M since the same quarter in the previous year.

Its net income has dropped by 8.9% to $-1M since the same quarter in the previous year.

Finally, its free cash flow grew by 116.0% to $308K since the same quarter in the previous year.

Based on the above factors, Stereotaxis, Inc gets an overall score of 3/5.